Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 4, 2013
Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia
Nageswara Rao Dunna, Sugunakar Vure, K Sailaja, et al.
The Journal of the Association of Physicians of India
|
February 10, 2012
Multiple myeloma presenting with hepatosplenomegaly
Krishna Mohan Mallavarapu, Senthil Rajappa, Vijay Gandhi Linga, et al.
Indian Journal of Pathology & Microbiology
|
September 22, 2007
Leukemia as a second malignancy
Megha S Uppin, T Roshni Paul, Senthil Rajappa, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
February 12, 2014
Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate
Senthil Rajappa, Krishna Mohan Mallavarapu, Sadashivudu Gundeti, et al.
Indian Journal of Cancer
|
March 28, 2022
Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Results from a Phase IV study in India
Prabhat S Malik, Vanita Noronha, Deepak Dabkara, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
December 19, 2012
Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis
Somanath Padhi, Tara Roshni Paul, Sundaram Challa, et al.
South Asian Journal of Cancer
|
April 18, 2017
Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy
Senthil Rajappa, Dinesh Chandra Doval, Jaydip Biswas, et al.
JCO Global Oncology
|
June 8, 2021
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
Sudeep Gupta, Senthil Rajappa, Suresh Advani, et al.
World Journal of Hepatology
|
August 18, 2022
Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?
Senthil Rajappa, Kun-Ming Rau, Palanki Satya Dattatreya, et al.
Indian Journal of Public Health
|
September 25, 2024
Current Practices in Genetic Testing for Prostate Cancer: The Indian Scenario
Ganesh Bakshi, Senthil Rajappa, Amit Joshi, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 4, 2013
Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia
Nageswara Rao Dunna, Sugunakar Vure, K Sailaja, et al.
The Journal of the Association of Physicians of India
|
February 10, 2012
Multiple myeloma presenting with hepatosplenomegaly
Krishna Mohan Mallavarapu, Senthil Rajappa, Vijay Gandhi Linga, et al.
Indian Journal of Pathology & Microbiology
|
September 22, 2007
Leukemia as a second malignancy
Megha S Uppin, T Roshni Paul, Senthil Rajappa, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
February 12, 2014
Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate
Senthil Rajappa, Krishna Mohan Mallavarapu, Sadashivudu Gundeti, et al.
Indian Journal of Cancer
|
March 28, 2022
Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Results from a Phase IV study in India
Prabhat S Malik, Vanita Noronha, Deepak Dabkara, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
December 19, 2012
Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis
Somanath Padhi, Tara Roshni Paul, Sundaram Challa, et al.
South Asian Journal of Cancer
|
April 18, 2017
Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy
Senthil Rajappa, Dinesh Chandra Doval, Jaydip Biswas, et al.
JCO Global Oncology
|
June 8, 2021
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
Sudeep Gupta, Senthil Rajappa, Suresh Advani, et al.
World Journal of Hepatology
|
August 18, 2022
Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?
Senthil Rajappa, Kun-Ming Rau, Palanki Satya Dattatreya, et al.
Indian Journal of Public Health
|
September 25, 2024
Current Practices in Genetic Testing for Prostate Cancer: The Indian Scenario
Ganesh Bakshi, Senthil Rajappa, Amit Joshi, et al.
Page
of 6